Prescription drug · ANDA
Betamethasone Dipropionate NDC 71335-2715
Betamethasone dipropionate .5 mg/g · Ointment · Topical · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-2715-1 | 71335271501 | 1 TUBE in 1 CARTON (71335-2715-1) / 45 g in 1 TUBEMarketed from Jul 28, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Betamethasone Dipropionate
- Generic name (nonproprietary)
- betamethasone dipropionate
- Active ingredients
- Betamethasone dipropionate — .5 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215847
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 71335-2715_c83c993e-71a3-41b4-8d09-0dd5cfbcae22SPL ID c83c993e-71a3-41b4-8d09-0dd5cfbcae22SPL set ID 52c0e92f-986e-45e7-99cf-9a13ac386b1dRxCUI 197405UNII 826Y60901U
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335271501followed by a unit qualifier and the quantityPackage 71335-2715-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 215847
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 72162-1415 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-9323 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-9324 |
| Betamethasone Dipropionate | Betamethasone dipropionate .5 mg/g | OintmentTopical | Padagis Israel Pharmaceuticals Ltd | 45802-505 |